PROCEPT BioRobotics Corporation (PRCT) Misses Q4 EPS by 1c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $68.24 million versus the consensus estimate of $66.83 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval